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Insulin-like growth factor-ll (IGF-II) is highly expressed in fetal tissues and may act 
as an autocrine growth factor during early embryogenesis. The SH-SY5Y human 
neuroblastoma cell line also expresses IGF-II and its receptors and responds to 
exogenous IGF-II with increased DNA synthesis, cell division, and neuritic out- 
growth. For this study, we tested the hypothesis that ICF-II mediates autocrine 
growth of SH-SY5Y cells in serum-free media. SH-SY5Y cells plated at high 
densities proliferated in serum-free media, whereas sparsely plated cells did not. 
IGF-II mRNA levels increased within 24 hours of serum deprivation and were 
associated with increased immunoreactive IGF-II protein. Exogenous addition of 
IGF-II increased 'H-TdR incorporation and cell number in a dose- and time- 
dependent fashion. By nuclear labelling experiments using 5-8rOmO-2'  deoxyuri- 
dine (BrdU), we detected a twofold higher percentage of S phase nuclei after a 
24-hour incubation in IGF-II. Treatment of SH-SY5Y cells with anti-IGF-ll antibod- 
ies in serum-free media inhibited cell proliferation, and this inhibition was par- 
tially overcome by the  addition of increasing concentrations of IGF-II. Collec- 
tively, our results indicate that IGF-II mediates an autocrine growth mechanism in 
SH-SYSY cells that is associated with increased IGF-II expression. 
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Insulin-like growth factor I1 (IGF-11) belongs to a 
family of proteins that exerts insulin-like metabolic 
and growth-promoting effects on many tissues (Rot- 
wein, 1991). In developing fetal neuroblasts, IGF-I1 
stimulates neuritic outgrowth, DNA synthesis, and cell 
proliferation (Bothwell, 1982; Recio-Pinto et al., 1986; 
DiCicco-Bloom and Black, 1988). IGF-I1 effects on cell 
growth have been shown to be mediated via interaction 
with specific transmembrane proteins, the type I and 
type I1 IGF receptors (Roth, 1988). The type I IGF re- 
ceptor is structurally homologous to the insulin recep- 
tor, with four (a,,Pa) transmembrane-spanning sub- 
units and an intracellular tyrosine kinase domain 
(Morgan et al., 1986). In  contrast to the type I IGF 
receptor, the type I1 IGF receptor is identical to the 
mannose-6 phosphate (Man-6 P) receptor and is respon- 
sible for targetting intracellular lysosomal enzymes 
(Morgan et al., 1987). IGF-11, acting through the type I 
or type I1 IGF receptor, has been shown to promote 
autocrine growth of other neuroblastoma cells (El- 
Badry et  al., 1989) and several nonneuronal tissues and 
cell types, including mouse embryos (Rappolee et al., 
1992) and muscle cells (Florini et al., 1991). 
The human IGF-I1 and IGF receptor genes are ex- 
pressed in cells of developing and adult mammalian 
nervous systems (Helper and Lund, 1990; Sara and 
Hall, 1990; McKelvie et al., 1992), and are also present 
in the SH-SY5Y human neuroblastoma cell line (Mar- 
tin et al., 1992). SH-SY5Y cells, thought to have arisen 
from the neural crest (Biedler et al., 19781, are often 
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used as  a model for neuronal development (PBhlman et 
al., 1990). IGF-I1 stimulates DNA synthesis and prolif- 
eration (Mattsson et al., 1986,1990; Feldman and Ran- 
dolph, 1991) of SH-SY5Y cells and also enhances neu- 
rite formation over a 7-day period (Recio-Pinto and 
Ishii, 1988; Feldman and Randolph, 1991). Endogenous 
production of IGF-I1 and IGF receptors in SH-SY5Y 
cells, combined with the responsiveness of these cells to 
exogenously added IGF-11, has led to the hypothesis 
that SH-SY5Y cells may use IGF-I1 as  an autocrine 
growth or survival factor (Pzhlman et al., 1990). 
In this study, we assayed the effects of endogenously 
produced and exogenously added IGF-I1 on the SH- 
SY5Y cell cycle. In serum-free media, SH-SY5Y cells 
exhibited density dependent growth, which was specifi- 
cally inhibited by anti-IGF-I1 antibodies. IGF-I1 expres- 
sion rapidly increased in serum-free media, a t  both the 
mRNA and protein levels. IGF-I1 stimulated SH-SY5Y 
cell DNA synthesis and entry into S phase but did not 
change the distribution of cells within the cell cycle. 
Our results are discussed in  the context of autocrine 
IGF-I1 mediated growth and effects on cell cycle. 
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MATERIALS AND METHODS 
Tissue culture flasks were purchased from Corning 
Glass Works (Corning, NY) and Costar (Cambridge, 
MA). Calf serum (CS) and Dulbecco's Modified Eagles 
Medium (DMEM) were from Gibco BRL (Gaithersburg, 
MD). Restriction enzymes were obtained from Boe- 
hringer Mannheim (Indianapolis, IN) and Gibco BRL. 
:j2P-dCTP was purchased from NEN Dupont (Boston, 
MA). Recombinant human IGF-I1 (from Bachem, Tor- 
rance, CA, or Bisource International, Westlake, CAI 
was stored in 10 mM acetic acid a t  -70°C. 5-Bromo-2' 
deoxyuridine (BrdU) was purchased from Sigma Chem- 
ical Co. (St. Louis, MO) and stored in 10 mM aliquots in 
water a t  -20°C. Murine monoclonal antirat IGF-11 an- 
tibody was purchased from Upstate Biotechnology 
(Lake Placid, NY). Monoclonal MOPC-21 antibody was 
purchased from Organon Teknika (Durham, NC). Dim- 
ethyl formamide was from Fluka (Ronkonkoma, NY). 
Unless indicated, all other chemicals were purchased 
from Sigma. 
Cell culture 
SH-SY5Y human neuroblastoma cells (Biedler e t  al., 
1978) were kindly provided by Dr. Stephen Fisher (Uni- 
versity of Michigan Medical Center). Cells were main- 
tained in DMEM and 10% CS at 37°C in a humidified 
atmosphere with 10% CO, and routinely subcultured 
after removal with trypsin-EDTA. 
DNA synthesis and cell proliferation assays 
SH-SY5Y cells were plated in &wells (3-12 x lo5 
cells per 3.5 mm well) in DMEM + 10% CS and allowed 
to grow for 2 days. Medium was then removed, cells 
were rinsed thoroughly with DMEM, and DMEM 2 
10% CS was added. 3H-TdR incorporation and cell num- 
ber were assayed in parallel wells either immediately 
(no media chan e) or  at various times after this change 
([methyZ-'H]thymidine, 6 pCi, 6,700 Ci/mol, NEN Du- 
Pont, Boston, MA) was added to each well for a 2-h 
incubation at 37°C. Cells were washed with PBS and 
5% TCA, and 1 ml of 0.1% SDS/O.lN NaOH was added 
for a 1-h incubation a t  37°C. An aliquot of the TCA- 
insoluble radioactivity was measured by liquid scintil- 
lation counting on a 2000CA scintillation counter 
(Packard, Downers Grove, IL). Cell number was deter- 
mined in parallel wells by trypan blue dye exclusion 
with a hemacytometer as  previously described (Feld- 
man and Randolph, 1991). Cell proliferation was mea- 
sured by a colorimetric assay that detects reduction of 
the tetrazolium salt MTT (Hansen et al., 1989). For 
these experiments, cells were plated (3-12 x lo4 cells/ 
cm2) in 100 pl media in 96-well plates. MTT (3(4,5- 
dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide) 
was added to a final concentration of 1 mg/ml for a 2-h 
incubation a t  37°C. Lysis buffer (0.1 ml of 50% dimethyl 
formamide, 20% wlv SDS, pH 4.7) was added and cells 
were incubated at 37°C overnight. Optical densities 
(OD) of individual wells were determined using a 
Dynatech MR700 ELISA reader (Dynatech Laborato- 
ries, Cleveland Heights, OH) with lysis buffer as the 
blank. After correction for nonspecific absorbance (630 
nm), there was a linear relationship between cell den- 
of media. For f * H-TdR incorporation studies, 'H-TdR 
sity and 570 nm OD within the range of densities used 
for this study. 
Analysis of DNA content 
SH-SY5Y cells were plated (3 x lo4 cells/cm2 in T75 
or T150 flasks) in DMEM + 10% CS and allowed to 
grow for 2 days. Medium was removed, cells were 
rinsed with DMEM, and fresh DMEM i- 10% CS or i 3  
or 10 nM IGF-I1 was added. After 0, 1, or 3 days, cells 
were removed by trypsinization and washed twice in 
HBSS (Hank's Balanced Salt Solution, Gibco BRL, 
Grand Island, NY). Cells were then fixed in ice-cold 
70% ethanol and stored a t  4°C. SH-SY5Y cells were 
washed twice in HBSS, stained overnight a t  4°C in 18 
Fgiml propidium iodide, 40 p.g/ml RNase A in HBSS, 
and passed 2-5 times through an 18-gauge syringe nee- 
dle to reduce clumping. Flow cytometry data were col- 
lected with the Epics Elite (Coulter Cytometry, Hia- 
leah, FL). Cell cycle analysis was performed using the 
Multicycle software program (Phoenix Flow Systems, 
San Diego, CA). 
BrdU cell proliferation assay 
For BrdU labelling, SH-SY5Y cells were plated 
(5 x lo4 cells per 3.5 cm well) on glass coverslips and 
maintained in 10% CS for 2 days. Cells were then 
rinsed with DMEM, and fresh DMEM i IGF-II(10 nM) 
was added. After 1,3, or 5 days, with a media change on 
day 4, BrdU was added to a final concentration of 1 FM 
for a 3-h incubation at  37°C. Cells were then rinsed in 
pre-warmed (37°C) HBSS and fixed for 5 min a t  room 
temperature in 4% paraformaldehyde in 0.1 M phos- 
phate buffer, pH 7.4. Cells were stored a t  4°C in 1%) 
paraformaldehyde. BrdU incorporation into nuclei was 
detected immunocytochemically, using an  antibody 
specific for BrdU. For BrdU labelling reaction, nuclei 
were denatured by washing for 30 min in 2N HC1/0.15% 
Triton-x 100. To prevent nonspecific antibody binding, 
cells were incubated for 30 min in 2% normal rabbit 
serum (Vector Laboratories, Burlingame, CAI. Cells 
were incubated with a monoclonal rat anti-BrdU anti- 
body (1:2500 in PBS, Accurate Chemical and Scientific, 
Westbury, NY) for 90 min in a moist chamber. A 
Vectastain rat ABC Immunoperoxidase kit (Vector 
Laboratories) was used for secondary antibody label- 
ling, with hydrogen peroxide, diaminobenzidine tet- 
rahydrochloride (DAB), and 5% nickel chloride. Cover- 
slips were wetmounted in a solution containing 50% 
glycerol, 0.5 M NaCO,, p.H 9.1, and 0.4 mg/ml p-phe- 
nylenediamine as an  antibleaching agent. Cells were 
visualized and the percentage of total nuclei labelled 
with BrdU determined by image analysis microscopy. 
Northern analysis and cDNA probes 
Northern analysis was performed essentially as pre- 
viously reported (Martin et al., 1992). SH-SY5Y cells 
(2.5 x l o 4  cells/cm2 in T150 flasks) were plated in 
DMEM/10% CS and allowed to grow for 2 days. The 
medium was then removed, cells were rinsed twice in 
DMEM, and DMEM ? 10% CS was added. RNA was 
isolated immediately (no media change) or at various 
times after this change of media, using guanidine thio- 
cyanate extraction (Chomczynski and Sacchi, 1987). 
Total RNA (20 pg) was separated by size in for- 










maldehyde-agarose gels and transferred to nylon Ny- 
tran membranes (Schleicher and Schuell, Keene, NH). 
Membranes were successively hybridized with 32-P- 
dCTP labelled (0.1-10 x 10' cpm/pg) cDNA probes for 
human IGF-I1 (bases 1-854 of a cDNA encoding exons 7, 
8, and part of 9 excised with Pst I) (Bell et al., 1984) and 
chicken p-actin (1.8 kb excised with Pst I) (Cleveland et 
al., 1980). Individual Nytran membranes were hybrid- 
ized by stripping and reprobing, as  described in the 
manufacturer's instructions (Schleicher and Schuell, 
Keene, NH). Relative OD for each hybridization was 
determined densitometrically by averaging several ex- 
posures in the linear range of the film. Experimental 
relative OD values were expressed as  a percentage of 
the untreated (time zero) controls and then divided by 
the percentage of untreated control values similarly 
obtained for p-actin hybridizations. 
Radioimmunoassay 
RIA was performed essentially as previously de- 
scribed (Cullen et al., 1991). SH-SY5Y cells were plated 
(3.7 x lo6 cells per T150 flask) and maintained in cul- 
ture for 2 days. Cells were washed with DMEM and 20 
ml fresh DMEM added. Medium was collected after 1,2, 
3, or 6 days, with a medium change on day 4. Medium 
was centrifuged (2 min, 1,000 rpm) to remove any cellu- 
lar debris and the protease inhibitors PMSF (0.1 pg/ml) 
and aprotinin (2 pg/ml) added to inhibit protein degra- 
dation. Medium was concentrated with Centriprep-3 
concentrators (MW cut-off = 3,000 Daltons, Amicon, 
Beverly, MA), and acetic acid added to a final concen- 
tration of 0.1 M prior to storage a t  -70°C. As described 
(Cullen et al., 1991), IGF binding proteins were sepa- 
rated from the IGF via double extraction with Sep-Pak 
CI8 columns (Millipore, Bedford, MA) (Osborne et al., 
1989) and assayed before and after column separation 
by an activated charcoal binding protein assay (Powell 
et al., 1987). Double extraction removed over 90% of the 
binding proteins. Samples or IGF-I1 standards, '"I- 
IGF-I1 (20,000-30,000 cpm, Amersham, Arlington 
Heights, IL) and 0.6 ng of rat monoclonal antibody 
against IGF-I1 (Upstate Biotechnologies, Lake Placid, 
NY) were incubated in RIA buffer (1% BSA, 0.1 M 
NaH,PO,, pH 7.4, 0.02% sodium azide) overnight. 
Bound IGF-11-antibody complexes were precipitated by 
addition of 5% human y-globulin and 25% polyethylene 
glycol, then removed and counted on a y-counter (Tm 
Analytic 1290, Tampa, FL). 
RESULTS 
Cell proliferation in serum-free media 
We measured the rate of SH-SY5Y cell proliferation 
in sparsely plated cells (3 x lo4  cells/cm2) over 6 days 
in serum and serum-free media by counting the number 
of viable cells. SH-SY5Y cells rapidly proliferated when 
cultured in serum, exhibiting a 14-fold increase in cell 
number after 6 days (Fig. 1). However, in serum-free 
media, sparsely plated cells exhibited no significant 
change in SH-SY5Y cell number over the entire 6-day 
treatment period (Fig. 1). Because cultured cells often 
exhibit density dependent growth, we asked whether 
densely plated SH-SY5Y cells could survive and prolif- 
erate in serum-free media. For these experiments, we 












Fig. 1. Effects of serum and serum-free media on SH-SY5Y cell pro- 
liferation. Cells were plated in DMEM + 10% CS and allowed to grow 
for 2 days, then rinsed with DMEM, and fresh DMEM (0 )  or 
DMEM + 10% CS (0 )  was added. Viable cells were counted by trypan 
blue dye exclusion either immediately (untreated) or after 1,2 ,3 ,  or 6 
days, with a media change on day 4. Cell numbers, expressed as 
cells x lo4, are the means 2 SEM of triplicate wells from a represen- 
tative experiment performed twice. Error bars were omitted where 
they were too small to be visible. 
serum, then washed and treated cells with serum-free 
media. Cell number was determined either immedi- 
ately (no media change) or after 1 or 3 days (Fig. 2a). At 
relatively low plating densities (3 and 6 x lo4 cells/ 
cm"), there were no significant changes in cell number 
over the entire 3-day serum-deprivation period. How- 
ever, at higher plating densities (9-12 x lo4 cells/cm2), 
cell number increased significantly after 3 days in se- 
rum-free media. To eliminate the possibility that SH- 
SY5Y cell growth in serum-free media was due to resid- 
ual serum, cells were rinsed and plated directly in 
serum-free media and cell number was measured after 
1-7 days by MTT assay (Hansen et al., 1989). SH-SY5Y 
cell plating efficiency was similar in serum-containing 
and serum-free media. We observed density dependent 
SH-SY5Y cell growth in these experiments also, as 
early as  one day after cell plating (Fig. 2b). The rate of 
SH-SY5Y cell division in serum-free media increased 
with increasing cell plating density, similar to our ob- 
servation for cells treated first with serum and then 
serum deprived (compare a and b in Fig. 2). When 
plated directly in serum-free media, SH-SY5Y cells 
(9 x lo4  cells/cm") exhibited a greater than twofold in- 
crease in cell number after 7 days (Fig. 2b). Cells plated 
more densely (12-21 x lo4 cells/cm') proliferated 
faster, exhibiting three- to sixfold increases in cell 
number after 5 days in serum-free media (Fig. 2b). OD 
readings were below the detectable range for cells 
plated at 3-6 x lo4 cells/cm2 and above the detectable 
range after 7 days for cells plated at 18 and 21 cells/cm2. 
SH-SYBY cells produce IGF-I1 protein 
The density dependence of SH-SY5Y cell prolifera- 
tion, combined with earlier observations that these 
cells express IGF-I1 mRNA and IGF receptors (Martin 
et al., 19921, suggested the presence of an IGF-I1 medi- 
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Fig. 2. Density dependent SH-SY5Y cell proliferation in serum-free 
media. Cells were plated in serum, then serum deprived (A) or plated 
directly in serum-free media (B). In A, cells were plated in 
DMEM + 10% CS (6-well dishes at  3-12 x lo4 cells/cm', as indicated 
in the legend) and allowed to grow for 2 days. Cells were then rinsed 
with DMEM, and fresh DMEM was added. Cell number was deter- 
mined by trypan blue dye exclusion either immediately (no media 
change) or after 1 or 3 days. Cell numbers, expressed as  cells x lo4, 
are means of triplicate wells 5 SEM. In B, cells were rinsed thor- 
ated autocrine growth mechanism. To determine 
whether IGF-I1 protein is also produced by these cells, 
we performed an IGF-11-specific RIA on SH-SY5Y cell- 
tioned media. These experiments were performed in 
serum-free media and not in the presence of serum, 
because serum contains IGF-I1 (Enberg and Hall, 
1984). SH-SY5Y cells also express several binding pro- 
teins that complex with IGF-I1 (Feldman et  al., 1992). It 
was therefore necessary to remove these binding pro- 
teins prior to IGF-I1 RIA. Fractions of eluate after two 
consecutive binding protein extractions were collected, 
pooled, and assayed by RIA. Dilutions of the pooled 
fractions exhibited similar inhibition of '251-IGF-II 
tracer binding to antibody as did human recombinant 
IGF-I1 (Fig. 3). The concentration of immunoreactive 
IGF-I1 present in SH-SY5Y cell serum-free conditioned 
media after 3 days was 1.31 * 0.11 nM (9.68 k 0.84 
ng/ml). 
Regulation of IGF-I1 gene expression 
RIA of serum-free media conditioned by SH-SY5Y 
cells for 1, 2, 3, or 6 days revealed a steady increase in 
the amount of immunoreactive IGF-I1 (Fig. 4). The con- 
centration of immunoreactive IGF-I1 increased over 
twofold between 1 and 3 days, from 0.47 * 0.04 nM 
(3.48 k 0.30 ngiml) to 1.31 ? 0.11 nM (9.68 * 0.84 ngi 
ml) and did not change thereafter (Fig. 4). The concen- 
tration of immunoreactive IGF-I1 after 6 days was 
1.30 * 0.16 nM (9.62 * 1.18 ngiml), similar to the con- 
centration present after 3 days. Because there was a 
complete media change on day 4, the concentration of 
IGF-I1 present in SH-SY5Y cell conditioned media after 
6 days represents the total cumulative amount pro- 
duced by these cells in 2 days. This value may therefore 
underestimate the amount of IGF-I1 produced by SH- 
SY5Y cells in 6 days. As described (Fig. 11, there was no 
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oughly in DMEM and plated in 96-wells (9-21 x lo4 cells/cm2, as 
indicated in the legend). Cell number was measured by MTT assay 
after 1 , 3 , 5 ,  or 7 days, with a media change on day 4. Relative OD (570 
nm) values are means of 8 wells t SEM. Cell number was signifi- 
cantly higher on each day compared to day 1 values for all five densi- 
ties tested (asterisks deleted for visual clarity). All data are from 
representative experiments performed twice. Error bars were omitted 
where they were too small to be visible. '"P < 0.05 compared to day 
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Fig. 3.  IGF-I1 immunoreactive protein in SH-SY5Y cell conditioned 
media. Cells were plated a t  2.5 x lo4 cells/cm' in T150 flasks for 2 
days in DMEM + 10% CS, then rinsed in DMEM, and 20 ml fresh 
DMEM added for an additional 3-day incubation. Medium was then 
collected and concentrated, binding proteins removed, and medium 
assayed for IGF-I1 levels. B/B, (%. of maximum) vs. ng of IGF-I1 (0) or 
yl of media ( 0 )  assayed is plotted on a logit-log scale. Maximum bind- 
ing was 32% of input radioactivity. K, = 2.2 nM. 
change in SH-SY5Y cell number in serum-free media 
under these plating conditions. 
Increased IGF-I1 was also detected at  the mRNA 
level. SH-SY5Y cells express three IGF-I1 RNA tran- 
scripts, 1.8, 4.8, and 6.0 kb in length (Martin et al., 
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Fig. 4. RIA of IGF-I1 protein from SH-SY5Y cell conditioned media. 
Cells were plated a t  2.5 x lo4 cells/cm2 in T150 flasks for 2 days in 
DMEM + 10% CS. Cells were then rinsed in DMEM and 20 ml fresh 
DMEM added for a 1,2,3, or 6 day incubation, with a media change on 
day 4. Media were collected and concentrated, binding proteins re- 
moved, and media assayed for IGF-I1 levels. Values in nM are the 
concentrations of IGF-I1 protein present in SH-SY5Y conditioned me- 
dia. Data are the means of two experiments ? SEM. *P < 0.05 com- 
pared b day 1 untreated control values by unpaired, two-tailed t-test. 
1992). By Northern analysis of total RNA from SH- 
SY5Y cells, we detected these same three IGF-I1 mRNA 
transcripts, with a relative abundance of 6.0 > 
4.8 > 1.8 kb (Fig. 5). We therefore used 6.0 kb IGF-I1 
mRNA as a representative measure for total IGF-I1 
mRNA content. IGF-I1 mRNA was rapidly up-regu- 
lated with serum deprivation, by sixfold after 1 day and 
by 37-fold after 6 days (Fig. 5a). Increased IGF-I1 
mRNA with serum deprivation was observed under the 
same plating conditions as our observed increase in 
immunoreactive IGF-I1 (compare Figs. 4 and 5). We 
also detected a tenfold rise in 6.0 kb IGF-I1 mRNA 
content after 3 days in serum and a 26-fold increase 
after 6 days (Fig. 5b). Thus, 6.0 kb IGF-I1 mRNA con- 
tent increased more rapidly in serum-free media than 
in serum. We detected a 30% reduction in p-actin 
mRNA content after 1 day in serum-free media, which 
was otherwise unchanged during the entire 6-day se- 
rum deprivation period (Fig. 5c). p-actin mRNA con- 
tent did not change significantly with time in serum. 
Effects of serum deprivation and IGF-I1 on DNA 
synthesis and the cell cycle 
Our finding that sparsely plated SH-SY5Y cells do 
not proliferate in serum-free media led us to speculate 
that serum deprivation may alter the rate of DNA syn- 
thesis or progression through the cell cycle. By 3H-TdR 
incorporation, we found that sparsely plated, serum- 
deprived cells synthesized DNA in a time-dependent 
fashion. 3H-TdR incorporation per cell decreased in SH- 
SY5Y cells by fivefold after 24 hours of serum depriva- 
tion, then increased back to control levels between 24 
and 48 hours (Fig. 6a). To better characterize the de- 
crease in 3H-TdR incorporation observed after 24 hours 
of serum deprivation, we performed a more detailed 
time course analysis of 3H-TdR incorporation in serum- 
free media (Fig. 6b). There was no detectable change in 
cell number with serum deprivation, so data are pre- 
sented as total JH-TdR incorporation instead of on a per 
cell basis, as for Figure 6a. We detected a similar de- 
crease in 3H-TdR incorporation during the first 24 
hours of serum deprivation, which steadily increased 
thereafter. 
Previous studies have shown that brief (20 hr) expo- 
sures to IGF-I1 stimulate DNA synthesis in SH-SY5Y 
cells (Mattsson et al., 1986, 1990). To better character- 
ize the response of SH-SY5Y cells to IGF-11, we mea- 
sured "H-TdR incorporation after 1-6 days of IGF-I1 
(1-10 nM) treatment. IGF-I1 stimulated 3H-TdR incor- 
poration per cell in a dose- and time-dependent fashion 
(Fig. 6a). Optimal stimulation of 3H-TdR incorporation 
relative to serum-free media was achieved after a 48-h 
incubation in 3 nM IGF-I1 (Fig. 6a). 3H-TdR incorpora- 
tion was also enhanced by 1 nM IGF-11, a concentration 
of IGF-I1 similar to that produced by SH-SY5Y cells 
(Figs. 4, 6a). Treatment with serum or IGF-I1 for 72 h 
resulted in an  apparent inhibition of 3H-TdR incorpora- 
tion relative to the serum-free control (Fig. 6a). How- 
ever, both IGF-I1 and serum increased cell number over 
time (Table 11, indicating that the rate of 3H-TdR incor- 
poration may decrease with increasing cell density 
(compare Fig. 6a and Table 1). 
To determine whether increased DNA synthesis with 
serum deprivation or IGF-I1 treatment could be associ- 
ated with increases in the number of cells synthesizing 
DNA, we performed nuclear labelling experiments 
(Fig. 7a, b). S phase nuclei were labelled by incorpora- 
tion of BrdU into DNA, which was then detected immu- 
nocytochemically with BrdU-specific antibodies. The 
number of BrdU-labelled nuclei was determined by mi- 
croscopic image analysis and expressed as a percentage 
of the total number of nuclei. Cells were plated at a 
relatively low density (5 x lo3 cells/cm2) for these ex- 
periments to facilitate visualization of labelled and un- 
labeled nuclei. In serum-free media, nuclear labelling 
index increased between 1 and 2 days (Fig. 7b), similar 
to our observed trend in 3H-TdR incorporation with 
serum deprivation (Fig. 6a). As early as 1 day following 
IGF-II(10 nM) treatment, BrdU nuclear labeling index 
was increased by two-fold relative to serum-free media 
(Fig. 7b). After 3- or 5-day incubations in IGF-11, nu- 
clear labelling index was decreased relative to the se- 
rum-free controls (Fig. 7b). 
Serum deprivation and IGF-I1 treatment could also 
regulate the SH-SY5Y cell cycle period. For these ex- 
periments, we assayed DNA content by flow cytometry 
over a 3-day incubation period in the presence or ab- 
sence of IGF-I1 or serum. In serum-treated cells there 
was a relatively constant proportion of cells in each 
phase of the cell cycle, at all time points tested (Table 
2). In contrast, cells treated with serum-free media ex- 
hibited varying percentages of cells in each phase of the 
cell cycle. After the first 24 h of serum deprivation, 
there was a greater than twofold decrease in the per- 
centage of cells in S phase relative to serum-treated 
cells, with a corresponding increase in the percentage of 
cells in GdG, (Table 2). After 3 days in serum-free 
media, the percentage of cells in S-phase was similar to 
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Fig. 5. Northern analysis of IGF-I1 mRNA. SH-SY5Y cells were 
plated at  2.5 x lo4  cellsicm' for 2 days in DMEM + 10% CS, rinsed in 
DMEM, then treated with DMEM i 10V CS. A. Autoradiograph from 
Northern blot of IGF-I1 and p-actin mRNA. RNA was isolated either 
immediately (untreated) or after 1, 2, 3, or 6 day incubation, with a 
media change on day 4. Northern analysis was performed with "'P- 
labelled cDNA probes for IGF-I1 and p-actin, as indicated in Materials 
and Methods. Days are indicated above each lane; RNA transcript 
sizes in kb are listed a t  the right of each autoradiograph. Autoradio- 
graphs exposed 8 h (IGF-11) and 4 d (p-actin). B and C. Densitometric 
analysis of IGF-I1 (B) and p-actin ( C )  mRNA. Autoradiographs from 
that of serum-treated cells, indicating that cells re-en- 
ter S phase sometime between 1 and 3 days after trans- 
fer to serum-free media. With serum deprivation, the 
ercentage of cells in S followed a time course similar to 
'€I-TdR incorporation and BrdU nuclear labelling in- 
dex (compare Figs. 6, 7 with Table 2). Treatment of 
SH-SY5Y cells with IGF-I1 (1-10 nM) for 24 h had no 
significant effects on the percentage of cells in S phase 
relative to serum-free media (Table 2 ) .  The percentage 
of cells in G,/M was lower in serum-free media than in 
serum treated cells at all time points tested. 
Antibodies against IGF-I1 block proliferation 
To determine whether endogenously produced IGF-I1 





0 0% cs 
0 10% cs 
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0 1 2 3 4 5 6  
Time (d) 
multiple exposures of the experiment shown in A and at least three 
additional experiments were quantitated using relative OD, as de- 
scribed in Materials and Methods. Values in B are means 2 SEM of 
the ratio of 6.0 kb IGF-I1 mRNA relative OD to p-actin relative OD, 
expressed as a percentage of time zero untreated control. Values in C 
are means i SEM of p-actin relative OD expressed as a percentage of 
time zero untreated control. In C, the number the observations is 
indicated in parentheses above each time point. "P < 0.05 compared to 
time zero untreated control values for 0% CS (01 or 10% CS ( 0 )  by 
unpaired, two-tailed t test. 
performed proliferation assays using anti-IGF-I1 anti- 
bodies. In these experiments, SH-SY5Y cells were 
plated in serum-free media in the presence or absence 
of IGF-I1 and IGF-I1 antibodies, and cell number was 
measured by the MTT assay (Hansen et al., 1989). In 
serum-free media alone, SH-SY5Y cell number in- 
creased threefold after 5 days in serum-free media 
(Fig. 8a). Addition of IGF-I1 (1-10 nM) increased cell 
number above the serum-free media control a t  all time 
points tested, whereas in the presence of anti-IGF-I1 
antibody, SH-SY5Y cell number did not change over 
the entire 7-day incubation period (Fig. 8a). Addition of 
increasing concentrations of IGF-I1 with the anti- 
IGF-I1 antibody prevented the decrease in cell number 
observed with the antibody alone, whereas isotypic 
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Fig. 6. Effects of IGF-I1 (A) and serum deprivation (A,B) on "H-TdR 
incorporation. SH-SYBY cells were plated at  3 x lo4 cells/cm' in 
DMEM + 10% CS for 2 days, then rinsed in DMEM and treated with 
DMEM t IGF-I1(1,3 or 10 nM) or 10'h CS. "H-TdR incorporation and 
viable cell number (determined by trypan blue dye exclusion) were 
measured in parallel wells either immediately (untreated) or after 1, 
2 , 3 ,  or 6 days, with a media change at  day 4. Values in A, expressed as 
cpm per cell are means of triplicate wells * SEM. Values in B, ex- 
pressed as cpm X lo4, are means of triplicate wells ? SEM. All data 
are from representative experiments performed twice. In A, untreated 
control = 0.94 i 0.17 cpmlcell. Error bars were omitted where they 
were too small to  be visible. 
MOPC-21 antibody had no significant effect on cell 
number (Fig. 8b). 
DISCUSSION 
IGF-I1 is up-regulated in serum-free media 
In this study, we found that SH-SY5Y cells actively 
proliferate in serum-free media if plated at high densi- 
ties. Density-dependent cell growth has been observed 
previously in other cell types, including keratinocytes 
(Shipley et al., 1989), and can indicate the presence of 
a concentration-dependent, endogenously produced 
growth-promoting activity (Cook et al., 1991). Using a 
RIA, we detected immunoreactive IGF-I1 protein in SH- 
SY5Y cell conditioned media at a concentration (1.5 
nM) within the range of IGF-I1 concentrations shown to 
stimulate DNA synthesis. These results suggest that  in 
the absence of serum, SH-SY5Y cells continuously syn- 
thesize and secrete IGF-I1 protein. The concentration of 
immunoreactive IGF-I1 present in SH-SY5Y cell media 
increased with time, to more than threefold after 3 
days. This result is consistent with an  earlier report in 
mouse muscle cell conditioned media showing in- 
creased IGF-I1 protein with low serum (Florini et al., 
1991). Similar increases in IGF-I during serum depri- 
vation have been reported in human fibroblasts (Clem- 
mons and Shaw, 1983) and lung cancer cells (Macaulay 
et al., 1990). 
We also observed increased IGF-I1 mRNA within 1 
day of serum deprivation. This increase in IGF-I1 
mRNA was not associated with an  increase in cell num- 
ber but rather with a sharp decline in the rate of DNA 
synthesis. These observations suggest that IGF-I1 ex- 
pression in low density cells is up-regulated a t  the 
mRNA level by mechanisms associated with growth 
arrest. We also observed a steady rise in IGF-I1 expres- 
sion with time in serum-containing media under condi- 
tions where the rate of DNA synthesis also decreased. 
We speculate that endogenously produced factors in 
SH-SY5Y cell conditioned media stimulate IGF-I1 ex- 
pression and that this effect is density dependent. One 
obvious candidate for such a feedback control mecha- 
nism of IGF-I1 expression is IGF-I1 itself. Our findings 
are consistent with studies in mouse muscle cells where 
increased IGF-I1 mRNA is detected within 16 h after 
transfer to low-serum media (Tollefsen et al., 1989; Flo- 
rini et al., 1991). IGF-I1 up-regulation has also been 
TABLE 1. Time course of berum deprivation and IGF-I1 effects on cell number' 
1 -~ ~ Condition 
0% CS 
1nM IGF-I1 




37 91 i 4 55 
32 90 ? 3.79 
39 20 i 345 
76 12 i 133 
Cells ( x  10") __ ~ -~ ~ - 
Day _ _ ~  - __ - 
'3 
45 75 + 0 38 
39 25 i 5 90 
73 20 i 4 53 
60 98 ? b 64 
250 68 + 10 7zp 
~~ 
2 
4304 I 2 3 1  
34 21 k 3 42 
25 62 ? 149 
39 46 -t 2 44 
148 83 i 5 63 
~ ~ _ _  
- -- 
- - -~ 
6 
52.54 i 1.01 
37 32 i 180' 
53 78 i 2 02 
61.58 + 3.16 
1036 17 i 68 13' 
~~ - 
~ ~~ ~ ~ 
'Cell number as determined by trypan blue dye exclusion. Data expressed as cells x 10' are means of triplicate wells from the 
same experiments shown in Figure 6a. 
' P  L.' 0.05 compared to O' i  CS control at rach time puint by unpaired, two-tailed t-test. 
1 I1 - 2 .  







Fig. 7. Effects of serum deprivation and IGF-I1 on SH-SY5Y nuclear 
labelling index. Cells 15 x 10' cells/cm') were plated onto glass cover- 
slips and allowed to grow in DMEM + 10% CS for 2 days. Cells were 
then rinsed with DMEM and fresh DMEM -t IGF-I1 (10 nM) added. 
After 1, 3, or 5 days, with a media change on day 4, cells were incu- 
bated with BrdU 110 (*M), then fixed and processed for BrdU immuno- 
cytochemistry a s  described in Materials and Methods. A. Brightfield 
photomicrograph of BrdU-stained SH-SY5Y cells. B. A minimum of 
250 total cells were counted by computerized microscopic image anal- 
ysis, and the number of BrdU-labelled nuclei expressed a s  a percent- 
age of the total. Values are  the means of triplicate coverslips -t SEM 
from a representative experiment performed twice. '?P e: 0.05 com- 
pared to 0% CS by unpaired, two-tailed t-test. 
TABLE 2. Effects of IGF-I1 and serum deprivation on SH-SY5Y cell cycle' 
G"/G, ((A) S 1 %  J G,/M (V ) 
~~~ ~~~ 
Day Day 
~ ~~ ~ D? ~~~ 
Condition 0 1 3 0 1 3 0 1 3 
~~ ~. ~~~ ~~~ ~~ ~~~ ~~ 
0% cs 47.2 78.3 66.1 46.2 8.2 29.4 6.5 13.5 4.6 
1nM 47.2 81.6 66.0 46.2 4.8 29.3 6.5 13.6 4.7 
3nM 47.2 82.3 67.3 46.2 5.3 29.2 6.5 12.3 3.5 
l0nM 47.2 81.3 62.9 46.2 9.4 3.7 6.5 9.2 0 
lo<% cs 47.2 55.1 70.0 46.2 33.4 20.2 6.5 11.5 9.8 
'The percentage ofcells in each phase of the cell cycle was determined by llow cytometry a s  described i n  Meterials and Methods 
Data are from a representative experiment performed twice 
detected after growth hormone treatment in hypophy- 
sectomized rat brain (Hynes et al., 1987) and in pri- 
mary human adrenal cells after exposure to ACTH 
(Voutilainen and Miller, 1987). We do not know 
whether increased IGF-I1 mRNA content is due to an  
increase in the rate of DNA transcription into RNA 
and/or in mRNA stability. In serum, actinomycin D 
studies indicate the half-life of the 6.0 kb IGF-I1 mRNA 
transcript is about 10 h (Sussenbach et al., 1991). 
Whereas other studies have reported changes in rela- 
tive expression levels of the 6.0 and 4.8 kb IGF-I1 
mRNA transcripts with serum stimulation (Meinsma 
et al., 1991), we observed no differences in the relative 
abundance of the 6.0,4.8, or 1.8 kb IGF-I1 transcripts in 
serum or serum-free media. 
Serum deprivation partially growth  arrests 
SH-SYBY cells 
Our observed increase in IGF-I1 mRNA after 24 h of 
serum deprivation was associated with sharp decreases 
in DNA synthesis and the percentage of cells in S 
phase. The percentage of cells in G,/G, phases of the 
cell cycle significantly increased during the initial 24-h 
serum deprivation. These results indicate that serum 
deprivation of low density SH-SY5Y cells initially ar- 
rests the great majority (80%) in G,/G, phases of the 
cell cycle. Our data are consistent with an earlier report 
showing a similar but shorter (12 h)  lag phase in DNA 
synthesis for fibroblasts arrested in G,/G, by serum 
deprivation (Pledger et al., 1977). After longer periods 
of serum deprivation, both DNA synthesis per cell and 
the percentage of cells in S phase returned to untreated 
control levels, suggesting a recovery mechanism that is 
able to overcome the initial serum deprivation shock on 
the cell cycle. We detected a small but significant frac- 
tion of cells in G,/M phases of the cell cycle with serum 
deprivation, indicating that some cells continue divid- 
ing in the absence of serum, even at  low densities. The 
small percentage of cells actively dividing in serum- 
free media was not associated with an increase in the 
number of viable cells, based on results from trypan 
blue dye assays. 
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Fig. 8. Effects of IGF-I1 and anti-IGF-I1 antibody on SH-SYSY cell 
proliferation. SH-SY5Y cells were washed in DMEM and plated in 
96-wells at 9 x lo4 cellsicm" in DMEM ? 1, 3 or 10 nM 1GF-I1 and i 
anti-IGF-I1 antibody (1 ~ g i m l l  and t MOPC-21 antibody (1 pglml). 
Cell proliferation was measured at various time points using the MTT 
assay. Symbols in A (0)  0% CS, (V ) 1 pplml anti-IGF-I1 antibody, ( v 1 
1 nM IGF-11, (0) 3 nM IGF-11, (MI  10 nM IGF-11. In B, cells were 
incubated for 3 days in the conditions listed on the x-axis (Ab = anti- 
IGF-I1 antibody). In A and B, optical densities (570 nm) are the means 
of eight wells + SEM from representative experiments performed 
three times. Error bars were omitted where they were too small to be 
visible. 
IGF-I1 increases DNA synthesis and cell 
cycling time 
IGFs have been shown to stimulate DNA synthesis 
whereas short (24 h) exposures stimulated 3H-TdR in- 
corporation. This observation is consistent with the 
24-h stimulation by JGF-11 reported by Mattsson et al. 
(1986). Increased 'H-TdR incorporation could indicate 
an  increase in the number of nuclei actively synthesiz- 
ing DNA or the rate of DNA synthesis. To assay for the 
first of these two possibilities, we performed nuclear 
labelling index experiments with BrdU in sparsely 
plated SH-SY5Y cells incubated in serum-free media 
with or without IGF-11. We found that IGF-11 (10 nM) 
increased the nuclear labeling index by twofold after 1 
day relative to serum-free media, suggesting exoge- 
nously added IGF-I1 promotes entry of SH-SY5Y cells 
into S phase. This finding corroborates data from 
Lundy and colleagues (1991) who reported increased 
BrdU nuclear labelling index after a 24-h treatment of 
embryonic chicken calvarial cells with IGF-II(O.3030 
nM). Similarly, DiCicco-Bloom and Black (1988) have 
shown that IGF-I1 increases the nuclear labelling index 
in fetal rat neuroblasts. Collectively, these observa- 
tions support the proposed role of IGF-I1 in promoting 
neuroblast entry into S phase. Interestingly, IGF-I1 in- 
hibited nuclear labelling index after 3 and 5 days, sim- 
ilar to its long-term effects on 3H-TdR incorporation. 
The reason for JGF-I1 inhibition of 'H-TdR incorpora- 
tion and BrdU labelling index after long exposures to 
IGF-I1 is not known. The half-life of IGF-I1 protein is 
about 4 h (Zapf et al., 1986), and it is possible that 
IGF-I1 degradation product inhibit DNA synthesis. Al- 
ternatively, IGF binding proteins, also produced by SH- 
SY5Y cells (Feldman et al., 19921, are known to modu- 
late IGF expression and function (Clemmons, 1991) and 
may serve a similar role here. Support for this notion 
comes from our observation that serum, which also con- 
tains IGF binding proteins, likewise inhibited 3H-TdR 
incorporation after long exposures. 
We performed flow cytometry experiments to test for 
effects of IGF-I1 on the distribution of cells in the cell 
cycle and overall cell cycle time. Addition of 1-10 nM 
IGF-I1 for 1 or  3 days had no significant effect on the 
percentage of cells in each phase of the cell cycle, rela- 
tive to serum-free media. Because BrdU experiments 
were performed a t  a lower density than the 3H-TdR and 
flow cytometry assays, it is possible that the potential 
effects of IGF-I1 on entry into S-phase are density-de- 
pendent. Alternatively, IGF-I1 induced increases in cell 
number and DNA synthesis could occur without affect- 
ing the distribution of cells in the cell cycle. This effect 
may result from an  IGF-I1 induced increase in the over- 
all cell cycling time. Chen and colleagues have ob- 
served a similar phenomenon with IGF-I, where they 
found that IGF-I increases the exit rate of fibroblasts 
from G,/G, to S, but does not affect the cycling fraction 
(Chen and Rabinovitch, 1989). 
(Mattsson et al., 1986) and progression of cel1s"through Evidence for autocrine IGF-I1 
mediated proliferation G,/G, + S phases of the cell cycle (Leof et al., 1982; DiCicco-Bloom and Black, 1988) and have therefore 
been termed "progression factors" (Leof et al., 1982). Expression of IGF-I1 at the RNA and protein levels 
Using DNA synthesis assays and flow cytometry, we and regulation of the SH-SY5Y cell cycle suggested 
tested the effects of IGF-I1 on SH-SY5Y cell S phase that these cells may use endogenously produced IGF-I1 
activity and the distribution of cells in various phases as a growth-promoting agent. To test this hypothesis, 
of the cell cycle. We found that long exposures (2-6 we determined the effects of anti-IGF-I1 blocking anti- 
days) to IGF-I1 inhibited "H-TdR incorporation, bodies on SH-SY5Y growth and survival in serum-free 
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media. We found that addition of anti-IGF-I1 to cells at 
the time of plating in serum-free media significantly 
decreased SH-SY5Y cell proliferation and that addition 
of exogenous IGF-I1 with the antibody prevented this 
inhibition. These results strongly suggest that  IGF-I1 
acts as an  autocrine growth factor in SH-SY5Y cells. 
This finding corroborates an earlier report by El-Badry 
and colleagues, who showed that other human neuro- 
blastomas use IGF-I1 as  an  autocrine mitogen (El- 
Badry et al., 1989). In comparison to the neuroblastoma 
cell lines and tissues used in their studies, SH-SY5Y 
cells exhibit relatively weak autocrine IGF-I1 growth. 
For example, the SK-N-AS line can survive for many 
months in serum-free media, whereas SH-SY5Y cells 
begin to detach from their substrate after about 1 week 
(El-Badry et al., 1989). One explanation for the differ- 
ent rates of neuroblastoma cell proliferation may be the 
presence of factors in the defined media or the poly-D 
lysine and fibronectin substrata used in their study. 
Autocrine IGF-I1 growth mechanisms have been de- 
tected in other systems as well, including early mam- 
malian embryogenesis (Rappolee et al., 19921, human 
placental development (Ohlsson et  al., 19891, and 
mouse muscle cell differentiation (Florini et al., 19911, 
as well as in other transformed cells such as rhabdomy- 
osarcoma, breast cancer, and stomach carcinoma (Os- 
borne et al., 1989; El-Badry et  al., 1990; Thompson et  
al., 1990). Our results in neuroblastoma cells further 
support growing evidence that IGF-I1 serves an  auto- 
crine or paracrine function in developing and trans- 
formed cells (Daughaday, 1990). 
In summary, the results of our experiments demon- 
strate that SH-SY5Y cells synthesize, secrete, and re- 
spond to IGF-I1 as part of an  autocrine growth mecha- 
nism. Increased IGF-I1 expression was associated with 
changes in DNA synthesis and the SH-SY5Y cell cycle 
and may be a necessary part of autocrine cell survival 
that is especially exaggerated in serum-free media. Fu- 
ture experiments will help determine whether IGF-I1 
binding to IGF receptors andior binding proteins is also 
regulated by serum withdrawal. Certainly, our finding 
that expression of IGF-I1 is enhanced in serum-free me- 
dia will provide a basis for the identification of clini- 
cally applicable agents for controlling neuroblastoma 
cell growth. 
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